Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-IL5 and Other Biotherapies in Cystic Fibrosis in French CF Centers : MAB-CF Cohort

NCT04256772 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04256772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04256772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-IL5 and Other Biotherapies in Cystic Fibrosis in French CF Centers : MAB-CF Cohort
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2019
Completion date
March 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis